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To assess the perception of risk of exposure in the management of hazardous drugs (HDs)
through home hospitalization and hospital units.
Material and methods
A questionnaire was released, at the national level, to health professionals with HD manage-
ment expertise. Questionnaire included 21 questions that were scored using a Likert scale:
0 (null probability) to 4 (very high probability). The internal consistency and reliability of the
questionnaire were calculated using Cronbach’s alpha and the intraclass correlation coeffi-
cient, respectively.
Results
144 questionnaires (response rate 70.2%) were obtained: 65 (45.1%) were nurses, 42
(28.9%) occupational physicians, and 37 (26.1%) were pharmacists. Cronbach’s alpha was
0.93, and intraclass correlation coefficient was 0.94 (95% CI 0.91–0.97; p-value < 0.001).
The mean probability was 1.95 ± 1.02 (median 1.9; minimum: 0.05; 1st quartile 1.1; 3rd
quartile 2.6; and maximum 4). Differences were observed in scoring among professional
groups (occupational physicians versus nurses (1.6/2.1, p = 0.044); pharmacists versus
nurses (1.7/2.1, p = 0.05); and occupational physicians versus pharmacists (1.6/1.7, p =
0.785), due mainly to the administration stage (p = 0.015).
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Conclusions
The perception of risk of exposure was moderate, being higher for nurses. It would be advis-
able to integrate HDs into a standardized management system (risk management model
applicable to any healthcare center) to improve the safety of health professionals.
Introduction
Concern about the safe handling of drugs by health workers has been present since Falck et al.
[1] detected, in 1979, mutagenicity in the urine of nurses who prepared cytostatics. This study
was a milestone because for the first time, the existence of a health risk in cases of continuous
exposure to some drugs was demonstrated, and from that moment, the concept of occupa-
tional exposure emerged.
The American Society of Hospital Pharmacists (ASHP) [2] introduced, in 1990, the term
“hazardous drug” (HD), which until then was exclusively associated with cytostatics. Later, in
2004, the National Institute for Occupational Safety and Health (NIOSH) [3] adopted this ter-
minology, giving rise to the internationally accepted definition today, which goes beyond the
field of cytostatics: “any drug that presents, in humans, one or more of the following hazard
criteria: carcinogenicity, teratogenicity or other developmental toxicity, reproductive toxicity,
low-dose organ toxicity, or genotoxicity or drugs with structure or toxicity profiles similar to
other hazardous drugs”.
HDs have been described as the greatest chemical hazard present in the health field and one
of the most dangerous chemical agents ever developed [4]. Therefore, there are priority recom-
mendations or strategies to improve safety that are developed by experts in workplace safety
entities, such as the Joint Commission [5], Occupational Safety and Health Administration
(OSHA) [6], the Pan American Health Organization (PAHO) [7] and the European Agency for
Safety and Health at Work (EU-OSHA) [8].
It is evident, then, that the process of handling HDs, constituted by circuits of high com-
plexity and with a large number of actors involved, involves important risks for health profes-
sionals, making it essential to ensure the safety of the process. Consequently, risk assessment
becomes one of the key points in the management and control of the HD process.
In this regard, it is important to note that the HD handling guide published in 2007 by the
International Society of Oncology Pharmacy Practitioners (ISOPP) [9] dedicates a specific sec-
tion to risk assessment. In the US, The Hazardous Drug Consensus Group (HDCG) provides
risk assessment as one of the key points in improving the safety of handling HDs because, as
explained, the results will depend on preventive measures that the organization will adopt
[10]. Finally, in Spain, the consensus document endorsed by different scientific societies,
unions, groups of health managers, and patient associations urges the Ministry of Health to
review and analyze critical points at different stages of the HD handling process [11].
Although the different stages of the HD handling process are carried out fundamentally
within health centers through the services of pharmacies and different clinical units involved
in patient care, it should be emphasized that exposure to risks occurs both during the stay in a
health center and in homes (where exposure affects both professionals and family members)
[12]. This is the case even more so when a patient is assigned to a hospitalization unit that
administers the medication in the patient’s home and in which the conditions in the workplace
(the patient’s home) are usually uncontrolled and lack, in most cases, direct supervision [8].
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In this context, the recent work published by Bernabeu et al. [13] identified the hazards and
described the chemical risks associated with the HD handling process, establishing the basis
for future risk assessments.
Consequently, the objective of this study was to evaluate perception of risk of exposure in
the management of HDs through HHUs and hospitalizations units.
Materials and methods
Study design
An electronic questionnaire was designed in Google Forms, with Likert scale response options,
for distribution through the Internet.
The specific questionnaire was agreed upon by a group of experts consisting of four hospital
pharmacists, one HHU physician, and one occupational health auditor pharmacist, taking pre-
vious work from Bernabeu et al. [14, 15] as a basis for the selection of the stages and dangers to
be addressed.
The final questionnaire (S1 and S2 Tables) included an introduction (profession of the
researched population: occupational physicians, nurse or pharmacist), 21 specific questions on
the subject under study and a closing section and online submission of the document once
completed.
The specific questions were classified into 9 sections: a) preservation (storage of the drug
under proper conditions of temperature, light and humidity); b) waste management; c) trans-
port to the place of administration; d) administration: previous stages; e) administration by
intravenous (IV) infusion; f) subcutaneous (SC), intramuscular (IM), intrathecal (IT) and IV
bolus administration; g) intravesical (IVe) administration; h) ophthalmic (OP) administration;
and i) administration: final stages.
All items were scored using a Likert scale with scores from 0 to 4 (0 = null perception that
exposure will not occur in any case; and 4 = very high probability: perception that exposure
would always occur). In any case, it was indicated that those items for which the appropriate
response was not known (due to lack of knowledge or experience in the specific operation or
stage) were left unanswered.
As a final phase of the questionnaire design, a pilot-pre-test was performed by allotting the
questionnaire in paper format to a group of 12 professional experts in HDs, belonging to the
different authors workplaces in order to ensure that the wording of the questions could be
understood by the respondents, making the correction considered appropriate. Finally, a test
form was completed to confirm that data was correctly recorded in the Excel file linked to the
Google form.
Cronbach’s α coefficient and the intraclass correlation coefficient (ICC) were calculated as
measures of internal consistency and reliability of the questionnaire (validation of the
questionnaire).
Population and scope of the questionnaire
The target population was health professionals (occupational physicians, nurses and pharma-
cists) with recognized experience in the management of HDs, either for their care work (both
at the hospital, outpatient or home level) or for their technical knowledge in the field. We
decided to survey the main profiles of health professionals involved in the managing of HDs,
who are responsible for carrying out the main international guidelines for handling HDs [14],
in order to procure results that reflect an integrated multidisciplinary vision (both technical-
theoretical and technical-practical knowledge). Additionally, this allows us to evaluate
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differences in risk perception between them, with the ultimate aim of better understanding
real risk and carrying out a more accurate risk assessment in subsequent works.
The size of this population was calculated based on the main objective of this study and the
estimation of Cronbach’s α coefficient and the intraclass correlation coefficient (ICC) as mea-
sures of internal consistency and reliability of the questionnaire. To calculate the minimum
necessary number of respondents, the expected values of both coefficients were assumed to be
those obtained in previous experiences (0.90 for both statistics), a confidence level of 95% and
a precision or amplitude of the interval of 5%. It was necessary to include a minimum of 142
people [16]. These calculations were determined from Bonett’s formulas [17, 18].
Implementation of the questionnaire
The questionnaire was disseminated nationally via email, which included a link of the elec-
tronic questionnaire, to a list of recruited professionals belonging to the Spanish group for the
development of oncology pharmacy (Grupo Español para el Desarrollo de la Farmacia Onco-
lógica—GEDEFO) of the Spanish Society of Hospital Pharmacy (Sociedad Española de Farma-
cia Hospitalaria—SEFH), to the management and quality working group of the Spanish
Society of Home Hospitalization (Sociedad Española de Hospitalización a Domicilio—
SEHAD) and to the professionals assigned to occupational risk prevention and preventive
medicine services through the National School of Occupational Medicine (Escuela Nacional
de Medicina del Trabajo—ENMT).
The questionnaire was conducted from November 18, 2019, to February 18, 2020, sending
a reminder every month through the same distribution list.
Information processing
The data were collected in an Excel table in Google Forms, periodically making backup tables
to safeguard the information. In cases where deviations and inconsistencies were detected, cor-
rections were made by consulting the original table.
Perception of risk of exposure
To determine the perceived risk of exposure, the following ranges were determined: low risk
from 0 to 1; moderate risk from 1.1 to 2; high risk from 2.1 to 3; and very high risk from 3.1
to 4.
Distribution of the results
The respondents were able to edit their answers after submitting if they detected an error or
wanted to modify any of their answers. Likewise, after the final submission, they could see
summary graphs for the set of results and for each item.
Statistical analysis
For the qualitative variable (profession), the absolute and relative frequencies (percentage)
were calculated. For the quantitative variables (the 21 items in the questionnaire), the mean
and standard deviation, the median, the maximum and minimum, and the first and third
quartiles were obtained.
To analyze the properties of the questionnaire and the relationships between its elements,
the internal consistency was checked using Cronbach’s alpha.
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To quantify the reliability of the measurements associated with the continuous quantitative
variables (items), the ICC and its 95% confidence interval were calculated (using the two-way
random-effects model and the multiple raters’ type).
To verify the normality of the variables, the Kolmogorov-Smirnov test (with Lilliefors cor-
rection) was used. The comparison of the medians between groups was performed using the
Kruskal-Wallis test, studying the association between groups with the Wilcox test and the Ben-
jamini & Hochberg method.
The level of significance used in all hypothesis tests was α� 0.05.
For the data analyses, R version 3.6.3 for Windows was used.
The datasets generated during and/or analysed during the current study are available from
the corresponding author by reasonable request.
Ethical considerations
The questionnaire and methodology for this study were approved by the Ethics Committee of
the University General Hospital (Ethics approval number: CEIC PI2017/93). Informed con-
sent was not required to participate in the questionnaire from the participants since it was
completely an anonymous and volunteer questionnaire and no personal data were obtained.
The professionals were recruited through distribution lists of the participating groups/socie-
ties. Administrator of those societies gave their consent prior to the distribution of the link to
the questionnaire, given the scientific interest of this work.
Results
Responses from a total of 144 professionals who met the criterion of having experience in the
management of HDs were obtained: 65 (45.1%) nurses, 42 (28.9%) physicians (occupational
physicians) and 37 (26.1%) pharmacists, representing a response rate of 70.2%.
Of the returned questionnaires, 115 (79.9%) were complete; items Q13, with 12 missing val-
ues, and Q11 and Q8, each with 9 missing values, accounted for the items with the most miss-
ing values.
Regarding the consistency of the questionnaire, the Cronbach’s alpha was greater than 0.9
in all cases. In addition, regarding the homogeneity of each item individually, a value greater
than 0.9 was obtained for all items. Consequently, an analysis of the disturbances showed that
it was not necessary to eliminate any of the items. The reliability of the questionnaire, mea-
sured by the ICC, was 0.94 (95% CI 0.91–0.97 and p-value < 0.001; see Table 1).
The normality test (Kolmogorov-Smirnov test, with Lilliefors correction) indicated that the
sample was not normally distributed, both in the overall results and in the stages; therefore, we
used nonparametric population comparison tests (global 3.52e-03; preservation 6.25e-41;
waste management 3.66e-10; transport 3.79e-12; and administration 4.97e-02).
Table 1. Measures of internal consistency and reliability.
Internal Consistency Reliability
α Cronbach Correlation coefficient Intraclass (95% CI)
Questionnaire 0.93 0.94 (0.91–0.97)
Questionnaire by occupational physicians 0.94 0.80 (0.70–0.89)
Questionnaire by nurses 0.93 0.87 (0.79–0.93)
Questionnaire by pharmacists 0.91 0.86 (0.79–0.93)
https://doi.org/10.1371/journal.pone.0253909.t001
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Results of the perception of risk of exposure to HDs
The analyses of the questionnaire responses resulted in the following central measures: mean
1.95 ± 1.02; median 1.9; minimum 0.05; 1st quartile 1.1; 3rd quartile 2.6; and maximum 4. The
statistics for each item are provided in Table 2, as well as the statistics for different stages of the
process and routes of administration.
A graphical representation of the distribution of the responses to the 21 questions, using a
boxplot, can be seen in (Fig 1).
Perception of risk of exposure according to professional group
The comparison of the medians by the Kruskal-Wallis test among the 3 groups of professionals
showed significant differences (p = 0.021). The Wilcox test, with the Benjamini & Hochberg
method, resulted in the following associations: occupational physicians versus nurses (1.6/2.1,
p = 0.044); pharmacists versus nurses (1.7/2.1, p = 0.05); and occupational physicians versus
pharmacists (1.6/1.7, p = 0.785). If there were differences among the professionals, according
to the different sections of the questionnaire, the differences were due to the route of adminis-
tration, mainly intravenous infusion (see Table 3).
The statistics for the central measures, broken down by the different professions of the
respondents, are provided in Table 4.
The average perception of risk of exposure for each of the items in the questionnaire, disag-
gregated by profession, is provided in Fig 2.
Discussion
Based on the responses obtained from health science professionals, this study was able to assess
the perceived probability of exposure to HDs through their management by HHU and hospital
units’ personnel. This study arises from the need to estimate the perception of the magnitude
of the risk associated with HD handling, based on the current working conditions in most
Spanish health centers, to determine, in later stages, the critical points of the process and estab-
lish adapted preventive measures that improve safety from the work point of view. To date and
except for omission, no studies have been published in the literature that quantify this risk in
the stages considered.
The good response rate achieved resulted from personalized recruitment, making a great
effort to have representative participation of different professional groups in the health field
with a high degree of knowledge about HDs (occupational physicians, specialized nurses in
HD administration and hospital pharmacists). It is not surprising that the professional group
with the most respondents was nursing staff because the stages considered in the questionnaire
are fundamentally the responsibility of this group.
In addition, the high degree of knowledge of the participants served as validation for the
results, and contributed to the low proportion of incomplete questionnaires. The questions
that presented the greatest number of missing values (or blank responses) corresponded to
items related to intravenous infusion administration, a route that has undergone a significant
technological evolution in recent years and that has a wide range of devices and equipment;
these devices and equipment have various levels of safety measures used in nonhomogeneous
manners in different health centers around the country, which could lead to a lack of experi-
ence in the handling of any of these devices by the respondents.
Cronbach’s alpha (with values close to 1) confirmed the consistency of the questionnaire,
which contributes robustness to the results. The ICC confirmed a high degree of agreement of
the observations made by the different participants. These values guaranteed the consistency
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and reliability of the questionnaire used to determine the perception of risk of exposure to
HDs.
Results of the perception of risk of exposure to HDs
The results obtained, in the questionnaire as a whole as in most of the items separately, with
scores that tended to the highest values, confirm the adequacy of the proposed probability
scale compared to that of the United States pharmacopoeia, in the consensus statement on the
management of HDs [10].
In this study, risk situations for workers that may arise during each stage of the process and
with each type of device currently marketed have been explored. Thus, the item that presented
the lowest risk of exposure was the one corresponding to transport of the HD to the place of
administration (Q3), a logical result given that it was assumed that HDs are transported in
Table 2. Central measures for the 21 items in the questionnaire and the statistics on perception of risk of exposure according to the different sections of the
questionnaire.
Item Minimum 1st quartile Median Mean ± SD 3rd quartile Maximum Perception of risk of exposure
Q1 0 1 1 1.6 ± 1.1 2 4 Middle
Q2 0 1 2 2.1 ± 1.2 3 4 High
Q3 0 1 1 1.2 ± 0.9 1 4 Middle
Q4 0 1 2 1.8 ± 1.1 2 4 Middle
Q5 0 1 2 1.6 ± 1.1 2 4 Middle
Q6 0 1 2 2.2 ± 1.1 3 4 High
Q7 0 2 2 2.4 ± 1.0 3 4 High
Q8 0 1 1 1.5 ± 1.0 2 4 High
Q9 0 1 2 1.9 ± 1.0 3 4 Middle
Q10 0 2 3 2.8 ± 1.0 4 4 High
Q11 0 1 2 1.8 ± 0.8 2 4 Middle
Q12 0 1 2 2.1 ± 1.1 3 4 High
Q13 0 1 2 1.9 ± 0.9 3 4 Middle
Q14 0 1 1 1.5 ± 0.9 2 4 Middle
Q15 0 1 2 2.3 ± 1.1 3 4 High
Q16 0 1 2 2.1 ± 1.0 3 4 High
Q17 0 1 2 2.3 ± 1.1 3 4 High
Q18 0 1 2 2.2 ± 1.1 3 4 High
Q19 0 1 2 2.0 ± 1.0 3 4 Middle
Q20 0 1 2 1.9 ± 1.1 3 4 Middle
Q21 0 1 2 1.9 ± 1.0 2 4 Middle
Preservation 0 1 1 1.5 ± 1.0 2 4 Middle
Waste manag. 0 1 2 1.9 ± 1.1 2.5 4 Middle
Transport 0 1 1 1.3 ± 1.0 2 4 Middle
Administration 0 1 2 2.0 ± 1.1 3 4 Middle
Administration IV 0 1 2 2.0 ± 1.1 3 4 Middle
Administration SI 0 1 2 2.1 ± 1.1 3 4 High
Administration IVe 0 1 2 2.2 ± 1.1 3 4 High
Administration OP 0 1 2 2.0 ± 1.1 3 4 Middle
Global 0.05 1.1 1.9 2.0 ± 1.0 2.6 4 Middle
Waste manag. = Waste management
IV = Intravenous perfusion; SI = Subcutaneous, intramuscular, intrathecal, intravenous bolus: IVe = Intravesical; OP = Ophthalmic.
https://doi.org/10.1371/journal.pone.0253909.t002
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airtight containers, minimizing the risk of damage to the HDs, on the one hand, and if damage
does occur, containing spills or leaks that may occur from the primary container [19]. The
item with the highest risk corresponded to the use of chambers without “Air Stop” filters dur-
ing administration of HDs by intravenous infusion, a result that agrees with the opinion of
other experts, who considered "flush operations" as high-risk actions [20]. These are special fil-
ters located in the drip chamber that prevent air from entering the infusion tube in the con-
tainer containing the HD. Some conventional HD infusion systems are devoid of this type of
filter, allowing the entry of air into the infusion line, forcing, if this occurs, the perfusion to
stop and flushing of the trapped air, with the consequent risk of dripping or spilling the HD.
Other theoretically critical points in which there is a risk of accidental exposure during
intravenous infusion administration are presented in the connection and disconnection of the
infusion lines as well as in the area around the spike, where there is a risk of exposure by
drops, or spills, by tears or breaks of the bag containing the HD or by an inadequate connec-
tion [20, 21]. Thus, the respondents rated as high risk the items corresponding to the connec-
tion of an HD to the infusion line (Q6) and the leakage of an HD through the spike that
Fig 1. Graphical representation of the distribution of the responses for the 21 items in the questionnaire.
https://doi.org/10.1371/journal.pone.0253909.g001
Table 3. Comparison of the medians of the different sections of the questionnaire according to profession or administration.
p-value
Preservation Waste management Transport Administration
Kruskal-Wallis test 0.151 0.127 0.134 0.015
Nurse-Pharmacist 0.224 0.165 0.693 0.067
Nurse-Occupational physician 0.224 0.342 0.168 0.022
Pharmacist-Occupational physician 0.564 0.384 0.168 0.623
Intravenous perfusion Subcutaneous, intramuscular, intrathecal, intravenous bolus Intravesical Ophthalmic
Kruskal-Wallis test 0.013 0.149 0.046 0.254
Nurse-Pharmacist 0.044 0.398 0.300 0.589
Nurse-Occupational physician 0.025 0.182 0.034 0.303
Pharmacist- Occupational physician 0.853 0.459 0.300 0.486
https://doi.org/10.1371/journal.pone.0253909.t003
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connects the extension to the HD container (Q7). However, low risk perception stands out, in
the case of leakage in the puncture area, when the HD connection to the extension is made by
luer-lock (Q8).
Regarding the disconnection points, the risk perception was lower than expected, with
moderate risk, both in the tree-type infusion system (system with multiple bags or tubing con-
nected through Y-site adapters) (Q12 and Q13) and in the valve infusion system (system that
uses one single bag and tubing) (Q14). Notably, the perception of risk of exposure of the valve
system versus the tree system was lower among the respondents, results that are in line with
the preferences shown by nursing staff in previous studies [22], probably because they are sim-
pler and more intuitive systems, as opposed to tree systems, which are complex to manage
(numerous clamping and unclamping to administer an HD and wash sera) and have a high
risk of accidental spills if personnel forget to clamp the secondary system. In addition, as a
recent study showed, in some cases, safety measures can introduce new risks and dangers, not
only for health personnel but also for the quality of the product and therefore for patient safety
[23]. Thus, Costero et al. [24] demonstrated that in tree-type systems, when the drip chamber
Table 4. Central statistics separated by section of the questionnaire and type of administration according to profession.
Item Minimum 1st quartile Median Mean ± SD 3rd quartile Maximum Risk of exposure perception
Nurse
Preservation 0 1 1 1.7 ± 1.2 2 4 Middle
Waste manag. 0 1 2 2.0 ± 1.2 3 4 Middle
Transport 0 1 1 1.5 ± 1.2 2 4 Middle
Administration 0 1 2 2.1 ± 1.2 3 4 High
Administration IV 0 1 2 2.1 ± 1.2 3 4 High
Administration SI 0 1 2 2.3 ± 1.2 3 4 High
Administration IVe 0 1.8 3 2.4 ± 1.2 3 4 High
Administration OP 0 1 2 2.1 ± 1.2 3 4 High
Pharmacist
Preservation 0 1 1 1.3 ± 0.6 2 2 Middle
Waste manag. 0 1 2 1.6 ± 0.9 2 4 Middle
Transport 0 1 1 1.4 ± 0.9 2 4 Middle
Administration 0 1 2 1.9 ± 1.0 3 4 Middle
Administration IV 0 1 2 1.9 ± 1.0 3 4 Middle
Administration SI 0 1 2 2.0 ± 1.0 3 4 Middle
Administration IVe 0 1 2 2.2 ± 1.2 3 4 High
Administration OP 0 1 2 2.0 ± 1.0 3 4 Middle
Occupational physician
Preservation 0 1 1 1.4 ± 1.1 1.8 2 Middle
Waste manag. 0 1 2 1.8 ± 1.0 2 4 Middle
Transport 0 1 1 1.1 ± 0.8 1 4 Middle
Administration 0 1 2 1.8 ± 1.0 2 4 Middle
Administration IV 0 1 2 1.8 ± 1.0 2 4 Middle
Administration SI 0 1 2 1.9 ± 1.0 2 4 Middle
Administration IVe 0 1 2 1.9 ± 1.0 2 4 Middle
Administration OP 0 1 2 1.8 ± 1.0 2 4 Middle
Global 0.05 1.1 1.9 2.0 ± 1.0 2.6 4 Middle
Waste manag. = Waste management
IV = Intravenous perfusion; SI = Subcutaneous, intramuscular, intrathecal, intravenous bolus: IVe = Intravesical; OP = Ophthalmic.
https://doi.org/10.1371/journal.pone.0253909.t004
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is empty, there is reflux of HD from the secondary system to the central serum washing system,
creating danger in the disconnection process. Thus, the frequency with which the drip cham-
ber is emptied and therefore a potential risk was moderate, according to the respondents
(Q11).
Despite all of the above and although there is no solid evidence showing benefits of one sys-
tem over the other, there is some consensus that the closed tree-type system presents fewer
chances of exposure (as it guarantees the absence of disconnections during the administration
process, and is therefore considered safer [20, 21].
The analysis of the results grouped by stages (preservation, transport, waste management
and administration) showed that administration, followed by waste management, were the
stages with the highest risk. This result is consistent with NIOSH considerations [3], which
establish that the preparation of an HD (a stage not evaluated in this questionnaire because it
is not performed in the home), together with administration and waste management, are the
phases of the HD handling process with the highest occupational risk.
Considering the specific route of administration, intravesical instillation of HDs is the route
that presents the greatest risk, followed by the administration of prefilled syringes (subcutane-
ous/intramuscular/intrathecal/intravenous bolus), both ahead of intravenous infusion or oph-
thalmic administration (administration of eye drops and intravitreal syringes). This result was
very interesting because in recent years, the efforts of the industry to design and develop
devices that help contain HD exposure have been mainly directed towards intravenous infu-
sion administration (probably due to the inherent complexity of this type of administration
and the greater frequency of use in the case of the HDs), leaving critical aspects of other
administration routes of “minority” HDs less attended. Hence, it is logical and coherent that
the perception of the risk of exposure of these routes is greater.
Perception of risk of exposure according to professional group
Overall, the perception of the risk of exposure to HDs was higher for nursing staff, with signifi-
cantly higher results when compared with both hospital pharmacists and the group of occupa-
tional physicians surveyed, finding no differences between the latter two. When these
differences were analyzed according to the different stages of the process (sections of the
Fig 2. Average perception of risk of exposure values for the 21 items in the questionnaire, by profession.
https://doi.org/10.1371/journal.pone.0253909.g002
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questionnaire), it was observed that the weight of these fell in the administration phase, mainly
in intravenous and intravesical perfusion administration, due to the discrepancies shown
between occupational physicians and pharmacists compared to the nursing group.
Similarly, when each of the questions of the questionnaire was analyzed individually, the
perception of risk of exposure by the nursing group was greater for all items except for 2, Q11
and Q18, the latter being related to the intravitreal administration of HDs, an activity carried
out mainly by ophthalmologists. Although there was no participation in the questionnaire of
ophthalmologists, both pharmacists and occupational physicians, based on their technical-the-
oretical knowledge, perceived these activities with a higher risk of exposure than the nursing
group whose technical knowledge is based primarily on the practice of nursing care.
These results were not surprising because, as already mentioned above, most of the activi-
ties evaluated in the questionnaire are carried out, in clinical practice, by nursing staff; there-
fore, it is consistent that they present a greater perception of risk of exposure, based on the
daily management of this type of medication and safety devices.
Limitations
For the analysis of risk, a subjective estimate of the risk of exposure in different scenarios was
made based on the perception of the participants in the questionnaire. Although perception
may not reflect actual exposure, there are no incidental records or solid evidence that allows
establishing the exact risk associated with each stage or procedure. Additionally, the quantita-
tive assessment of HD exposure, considered the gold standard in the risk assessment of chemi-
cal agents [25], is not applicable to HDs, as it involves a validated sampling strategy and
comparison with a reference limit value. In the case of HDs, there is no exposure threshold
below which there is certainty that the harmful effect will not occur [26, 27].
Conclusions
The perception of the risk of exposure associated with HD preservation, transport, administra-
tion, and waste management was generally moderate, thus tend to the mean values on the
probability scale. This result was considered consistent because the assessment of the percep-
tion of risk of exposure was carried out considering the existing prevention measures (safety
devices, closed system drug transfer devices and personal protective equipment). In turn, this
fact demonstrated that the use of all these measures does not completely eliminate what work-
ers consider as risky, and that there are still unresolved critical points in the process.
The perception of risk of exposure was higher for the nursing group for practically the
entire questionnaire, the group responsible for most of the activities analyzed in the question-
naire and probably the group with the most knowledge of the real risks of the process and the
critical potential exposure points therein. Nevertheless, the selection of different professional
healthcare profiles in the survey allowed us to analyze the operations with the greatest differ-
ence in the risk perception between groups of professionals and thus enable us to establish pre-
ventive measures which better adapt to each situation.
For all the above, HDs should be integrated into a standardized management system, that is
a comprehensive system for controlling the hazards associated with the HDs handling process,
applicable to any hospital, that allows us to identify which points in the process have the great-
est risk as well as how to control them by reporting each of the performed activities with the
ultimate aim to improve the safety of patients and health professionals, with resource efficiency
maximized and procedural incidents minimized, guaranteeing the quality and safety of the
HD handling process in HHUs and hospital units.
PLOS ONE Probability of exposure to hazardous drugs
PLOS ONE | https://doi.org/10.1371/journal.pone.0253909 July 1, 2021 11 / 14
It would be desirable that, in the future, a common methodology be followed for the risk
assessment of HDs that allows not only monitoring effective preventive planning but also
establishing a solid database for the evolution of working conditions that are produced so that
preventive management and control can improve day by day. In this sense, having technolo-
gies applied to HDs that allow configuring specific management systems in relation to the
management and traceability of HDs would provide enormous added value.
Supporting information
S1 Table. English version.
(DOCX)
S2 Table. Spanish version.
(DOCX)
Acknowledgments
The working groups that have collaborated in this study belong to the Spanish Society of Hos-
pital Pharmacy (Sociedad Española de Farmacia Hospitalaria—SEFH), the Spanish Society of
Home Hospitalization (Sociedad Española de Hospitalización a Domicilio—SEHAD) and the
National School of Occupational Medicine (Escuela Nacional de Medicina del Trabajo—
ENMT) of the Carlos III Health Institute (Instituto de Salud Carlos III—ISCIII). We thank
Andrés Navarro, Amparo Burgos, Jose Antonio Marcos and Chelo Jordán for their help in dis-
tributing the questionnaire.
To Habiba Chbab, master’s degree in English and Spanish for Specific Purposes and doc-
toral student in Professional and Audiovisual Translation (Research branch: medical transla-
tion), for her inestimable collaboration in the translation of this document.
Author Contributions
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Data curation: Mari Ángeles Bernabeu-Martı́nez, Julia Sánchez-Tormo.
Formal analysis: Pedro Garcı́a-Salom, Carmina Wanden-Berghe.
Funding acquisition: Carmina Wanden-Berghe.
Investigation: Julia Sánchez-Tormo.
Methodology: Pedro Garcı́a-Salom, Javier Sanz-Valero, Carmina Wanden-Berghe.
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